Scripps Health

 

Scripps Health
N

MASLD/MASH: Disparities and Considerations

By Scripps Health FEATURING Nadege Gunn
By Scripps Health FEATURING Nadege Gunn
0 views
April 3, 2024
Comments 0
Login to view comments. Click here to Login
New Treatments in Chronic Liver Disease 2024
20:09
Scripps Health

New Nomenclature for Steatotic Liver Disease

Feat. P. Pockros
26:08
Scripps Health

MASLD/MASH: Disparities and Considerations

Feat. N. Gunn
45:34
Scripps Health

Incretin-based Therapy for Metabolic Liver Disease

Feat. J. Frias
49:14
Scripps Health

Using Resmetirom (THR-β Agonist) in Your Practice for MASH

Feat. J. Gutierrez
44:24
Scripps Health

MASH Cases

Feat. N. Gunn, J. Frias, P. Pockros, J. Gutierrez
30:08
Scripps Health

Co-Localization of HCV and Addiction Services

Feat. A. Martinez
24:46
Scripps Health

What is the Road to HBV and HDV Functional Cures?

Feat. R. Gish
43:01
Scripps Health

Cholestatic Liver Disease 2024 Update

Feat. K. Kowdley
31:02
Scripps Health

Pharmacologic Management of Alcohol Use Disorder

Feat. R. Lee
49:36
Scripps Health

Management of Liver Masses

Feat. A. Deising
12:01
Scripps Health

Alcoholic Liver Diseases Panel Discussion/Q&A

Feat. A. Martinez, R. Gish, K. Kowdley, R. Lee, A. Deising
27:28
Scripps Health

Chronic Liver Disease and Liver Transplantation in Women

Feat. G. Choi
34:34
Scripps Health

Renal Dysfunction in the Cirrhotic Patient

Feat. P. Martin
14:31
Scripps Health

Liver Transplantation Panel Discussion/Q&A

Feat. G. Choi, P. Martin